← SynDRA
UNC2250
SynDRA canonical compound SYN1970737 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | MERTK |
| Mechanism of action | MER tyrosine kinase inhibitor |
All known targets
Mechanisms of action (all sources)
- MER tyrosine kinase inhibitor
Cross-references
Synonyms
- UNC 2250
- CHEMBL3092807
- (1R,4r)-4-((2-(butylamino)-5-(5-(morpholinomethyl)pyridin-2-yl)pyrimidin-4-yl)amino)cyclohexanol
- (1r,4r)-4-{[2-(butylamino)-5-[5-(morpholin-4-ylmethyl)pyridin-2-yl]pyrimidin-4-yl]amino}cyclohexan-1-ol
- trans-4-((2-(Butylamino)-5-(5-(morpholinomethyl)pyridin-2-yl)pyrimidin-4-yl)amino)cyclohexanol
- C24H36N6O2
- 4-[[2-(Butylamino)-5-[5-(morpholin-4-ylmethyl)pyridin-2-yl]pyrimidin-4-yl]amino]cyclohexan-1-ol
- SCHEMBL16435535
- SCHEMBL16438463
- BDBM308180
- HMS3740M13
- BCP09929
- EX-A2175
- UNC-5520
- BDBM50444042
- FD5023
- MFCD27992060
- s7342
- ZINC96170458
- AKOS026750288
- AKOS027338220
- ZINC102240028
- ZINC253387880
- CCG-269128
- SB52242
- US9649309, Compound UNC2250B
- NCGC00386394-03
- NCGC00386394-04
- AC-31423
- AS-55930
- DA-44178
- HY-15797
- FT-0742245
- A14143
- (1r,4r)-4-((2-(butylamino)-5-(5-(morpholinomethyl)pyridin-2-yl)pyrimidin-4-yl)amino)cyclohexan-1-ol
- (1r,4r)-4-(2-(butylamino)-5-(5-(morpholinomethyl)pyridin-2-yl)pyrimidin-4-ylamino)cyclohexanol
- trans-4-[[2-(Butylamino)-5-[5-(morpholinomethyl)-2-pyridyl]-4-pyrimidinyl]amino]cyclohexanol
- UNC-2250
- orb1306933
Look up UNC2250 in the interactive SynDRA portal →